Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment.
Dionisiotis
J
J
Zoukos
Y
Y
Thomaides
T
T
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009157:Myasthenia Gravis / Q000139:chemically induced*
D000276:Adjuvants, Immunologic; D016899:Interferon-beta